REPH insider trading

CIK 1588972

Recro Pharma, Inc.: insider trade history from SEC Form 4 filings.

Form 4 trades
344
Last 90 days
0
Buys / sells
7% / 49%
Insiders
28

REPH insider activity at a glance

FilingIQ tracks 344 insider transactions for REPH in filings since Jun 9, 2015. The most recent transaction is dated Mar 15, 2022. They were reported by 28 insiders.

Across the full history, 24 open-market purchases and 167 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

Latest REPH Form 4 filings

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Tickers with similar insider activity

Ranked next to REPH by Form 4 lines in the last 90 days, the number on each card.

Frequently asked

How many insider trades does FilingIQ track for REPH?
FilingIQ tracks 344 Form 4 insider transactions for REPH (Recro Pharma, Inc.), covering filings from Jun 9, 2015 onwards. 0 of those are dated within the last 90 days.
Are REPH insiders net buyers or net sellers?
Across the full Form 4 history for REPH, 24 transactions (7%) were open-market purchases and 167 (49%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does REPH insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

Methodology & sources

Every REPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.